MAC Clinical Research

MAC Clinical Research is a Contract Research Organisation (CRO) dedicated to conducting full-service global clinical trials for leading pharmaceutical and biotech companies. With a broad range of clinical research capabilities, including a Phase 1 Unit accredited by MHRA, the company specializes in memory conditions, neurology, and other therapeutic areas such as neuropsychiatric disorders, neurodegenerative diseases, inflammation, and pain. Since its establishment in 2002, MAC has completed over 200 studies across Phase I-IV, solidifying its position as the UK's leading therapeutically specialized clinical trial company with a global offering. To learn more, visit www.macplc.com and view the company's brochure at http://tinyurl.com/45f5vd48.

MAC Clinical Research is active on various social media platforms including Facebook @MACClinicalResearchCRO, Instagram mac_clinicalresearchcro, Twitter @MAC_Research, and YouTube MAC Clinical Research. Additionally, the company provides employment and career opportunities through clinicalresearchjobs.co.

The company operates in the Biotechnology industry and has the potential to attract investors who are interested in supporting innovative clinical research endeavors that aim to improve the quality of life. While specific details about the last investment and investors are not available, the company's extensive experience, specialized focus, and global capabilities make it a compelling prospect for potential investors.